Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference65 articles.
1. Management of bone metastases in patients with castration-resistant prostate cancer;Cathomas;Urol Int,2014
2. Prostate cancer: palliative care and pain relief;Thompson;Br Med Bull,2007
3. Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer;Vignani;Cancer Treat Rev,2016
4. Therapeutic management of bone metastasis in prostate cancer: an update;Zustovich;Expert Rev Anticancer Therapy,2016
5. Systemic therapy in men with metastatic castration-resistant prostate cancer: American society of clinical oncology and cancer care ontario clinical practice guideline;Basch;J Clin Oncol,2014
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer;Acta Oncologica;2024-07-05
2. Establishing a robust radioligand therapy program: A practical approach for North American centers;Cancer Medicine;2024-01-12
3. The Role of PET and SPECT Imaging in Prostate Cancer Targeted Alpha Therapy: When and How?;Applied Sciences;2023-02-01
4. Dosimetry in Radiopharmaceutical Therapy;Journal of Nuclear Medicine;2022-10
5. Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer;Prostate Cancer and Prostatic Diseases;2020-02-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3